Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19)
Morayma Reyes Gil, Mohammad Barouqa, James Szymanski, Jesus D. Gonzalez‐Lugo, Shafia Rahman, Henny H. Billett
Abstract
This cohort study assesses the prevalence of lupus anticoagulant (LA) positivity in patients with coronavirus disease 2019 (COVID-19) and examines the association of LA positivity with patient outcomes.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)MedicineCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Lupus anticoagulant2019-20 coronavirus outbreakDiseaseCohortSystemic lupus erythematosusAnticoagulantCohort studyHydroxychloroquineInternal medicineVirologyInfectious disease (medical specialty)ThrombosisOutbreakCOVID-19 Clinical Research StudiesSystemic Lupus Erythematosus ResearchLong-Term Effects of COVID-19